Back to Search
Start Over
Preprocedural Multimodality Imaging in Atrial Fibrillation.
- Source :
-
Circulation. Cardiovascular imaging [Circ Cardiovasc Imaging] 2022 Oct; Vol. 15 (10), pp. e014386. Date of Electronic Publication: 2022 Oct 18. - Publication Year :
- 2022
-
Abstract
- Atrial fibrillation (AF) is the most common arrhythmia worldwide and is associated with increased risk of heart failure, stroke, and death. In current medical practice, multimodality imaging is routinely used in the management of AF. Twenty-one years ago, the ACUTE trial (Assessment of Cardioversion Using Transesophageal Echocardiography) results were published, and the management of AF changed forever by incorporating transesophageal echocardiography guided cardioversion of patients in AF for the first time. Current applications of multimodality imaging in AF in 2022 include the use of transesophageal echocardiography and computed tomography before cardioversion to exclude left atrial thrombus and in left atrial appendage occlusion device implantation. Transesophageal echocardiography, cardiac computed tomography, and cardiac magnetic resonance are clinically used for AF ablation planning. The decision to use a particular imaging modality in AF is based on patient's characteristics, guideline recommendation, institutional preferences, expertise, and cost. In this first of 2-part review series, we discuss the preprocedural role of echocardiography, computed tomography, and cardiac magnetic resonance in the AF, with regard to their clinical applications, relevant outcomes data and unmet needs, and highlights future directions in this rapidly evolving field.
Details
- Language :
- English
- ISSN :
- 1942-0080
- Volume :
- 15
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Circulation. Cardiovascular imaging
- Publication Type :
- Academic Journal
- Accession number :
- 36256725
- Full Text :
- https://doi.org/10.1161/CIRCIMAGING.122.014386